The FRAGAMP study: Environmental and genetic factors in Parkinson's disease, methods and clinical features

Neurological Sciences

Volumn 31, Issue 1, 2010, Pages 47-52

  Nicoletti, Alessandra ^a   Pugliese, Pierfrancesco ^b   Nicoletti, Giuseppe ^b   Arabia, Gennarina ^b   Annesi, Grazia ^b   De Mari, Michele ^c   Lamberti, Paolo ^c   Gallerini, Simone ^d   Marconi, Roberto ^d   Epifanio, Antonio ^e   Morgante, Letterio ^e   Cozzolino, Autilia ^f   Barone, Paolo ^f   Torchia, Giuseppina ^g   Quattrone, Aldo ^b,g   Zappia, Mario ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d MISERICORDIA HOSPITAL   (Italy)

^e UNIVERSITY OF MESSINA   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Case control study; Epidemiology; Parkinson's disease

Indexed keywords

APOMORPHINE; CABERGOLINE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

AGE DISTRIBUTION; AGED; ARTICLE; BRADYKINESIA; CASE CONTROL STUDY; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DYSKINESIA; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; HAND TREMOR; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; QUESTIONNAIRE; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SLEEP DISORDER; SPOUSE; TREATMENT DURATION;

AGED; ANTIPARKINSON AGENTS; CASE-CONTROL STUDIES; DOPAMINE AGONISTS; DYSKINESIAS; ENVIRONMENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GEOGRAPHY; HUMANS; ITALY; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; QUESTIONNAIRES; SEQUENCE ANALYSIS, DNA; SEVERITY OF ILLNESS INDEX; SPOUSES;

EID: 76449100277     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-009-0182-z     Document Type: Article

References (23)

1. LML de Lau MMB Breteler 2006 Epidemiology of Parkinson's disease Lancet Neurol 5 525 535 10.1016/S1474-4422(06)70471-9 16713924 (Pubitemid 44262284)
2. EK Tan M Khajavi JI Thornby, et al. 2000 Variability and validity of polymorphism association studies in Parkinson's disease Neurology 55 533 538
3. JW Langston P Ballard JW Tetrud I Irwin 1983 Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 979 980 10.1126/science.6823561
4. P Pals B Van Everbroeck B Grubben, et al. 2003 Case-control study of environmental risk factors for Parkinson's disease in Belgium Eur J Epidemiol 18 1133 1142 10.1023/B:EJEP.0000006639.05690.92 14758870 (Pubitemid 38083959)
5. DJ Gelb E Oliver S Gilman 1999 Diagnostic criteria for Parkinson disease Arch Neurol 56 33 39 10.1001/archneur.56.1.33 (Pubitemid 29046907)
6. MF Folstein SE Folstein PR McHugh 1975 "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 189 198
7. M Hamilton 1960 A rating scale for depression J Neurol Neurosurg Psychiatry 23 56 62 10.1136/jnnp.23.1.56
8. E Magni G Binetti A Padovani, et al. 1996 The Mini-Mental State Examination in Alzheimer's disease and multi-infarct dementia Int Psychogeriatr 8 127 134 10.1017/S1041610296002529 (Pubitemid 26248778)
9. A Schrag P Barone RG Brown, et al. 2007 Depression rating scales in Parkinson's disease: critique and recommendations Mov Disord 22 1077 1092 10.1002/mds.21333 17394234 (Pubitemid 47067217)
10. MM Hoehn MD Yahr 1967 Parkinsonism: onset, progression, and mortality Neurology 17 427 442
11. Fahn S, Elton RL, the members of the UPDRS development committee (1987) Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB (eds) Recent developments in Parkinson's disease. MacMillan, London, pp 153-163
12. MR Munetz S Benjamin 1988 How to examine patients using the Abnormal Involuntary Movement Scale Hosp Community Psychiatry 39 1172 1177
13. Andreasen NC (1984) Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa, Iowa City
14. Stata corp (1995) STATA statistical software: release 6.0. STATA corporation, College Station
15. M Bornebroek M Breteler 2003 Studying risk factors for Parkinson's disease Eur J Epidemiol 18 1113 1114 10.1023/B:EJEP.0000006533.78656.b3 14758867 (Pubitemid 38083956)
16. LR Cardon JI Bell 2001 Association study designs for complex diseases Nat Rev Genet 2 91 99 10.1038/35052543 (Pubitemid 33674000)
17. R Frigerio A Elbaz KR Sanft, et al. 2005 Education and occupations preceding Parkinson disease: a population-based case-control study Neurology 65 1575 1583 10.1212/01.wnl.0000184520.21744.a2 (Pubitemid 41689471)
18. JA Firestone T Smith-Weller G Franklin, et al. 2005 Pesticides and risk of Parkinson disease: a population-based case-control study Arch Neurol 62 91 95 10.1001/archneur.62.1.91 15642854 (Pubitemid 40105040)
19. E Miyawaki K Lyons R Pahwa, et al. 1997 Motor complications of chronic levodopa therapy in Parkinson's disease Clin Neuropharmacol 20 523 530 10.1097/00002826-199712000-00004
20. P Martinez-Martin AH Schapira F Stocchi, et al. 2007 Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients Mov Disord 22 1623 1629 10.1002/mds.21586 17546669 (Pubitemid 47477925)
21. M Emre D Aarsland R Brown, et al. 2007 Clinical diagnostic criteria for dementia associated with Parkinson's disease Mov Disord 22 1689 1707 10.1002/mds.21507 17542011 (Pubitemid 47597592)
22. A Schrag Y Ben Shlomo N Quinn 2002 How common are complications of Parkinson's disease? J Neurol 249 419 423 10.1007/s004150200032 11967646 (Pubitemid 34304615)
23. Gordis L (ed) (1996) Epidemiology. W.B. Saunders Company, Philadelphia